MEDBX
Price
$11.96
Change
-$0.02 (-0.17%)
Updated
May 14 closing price
Net Assets
7.01B
MEDCX
Price
$11.95
Change
-$0.01 (-0.08%)
Updated
May 14 closing price
Net Assets
7.01B
Ad is loading...

MEDBX vs MEDCX

Header iconMEDBX vs MEDCX Comparison
Open Charts MEDBX vs MEDCXBanner chart's image
MFS Emerging Markets Debt B
Price$11.96
Change-$0.02 (-0.17%)
VolumeN/A
Net Assets7.01B
MFS Emerging Markets Debt C
Price$11.95
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.01B
MEDBX vs MEDCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEDBX vs. MEDCX commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDBX is a Hold and MEDCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
MEDBX (7.01B) and MEDCX (7.01B) have equal amount of cash in the bank . MEDCX (5.77) and MEDBX (5.77) have matching dividends . MEDBX was incepted earlier than MEDCX: MEDBX (23 years) vs MEDCX (23 years). MEDBX (1.82) and MEDCX (1.82) have similar cost to investors . MEDBX (58.00) and MEDCX (58.00) have comparable annual turnover. MEDBX (1000) and MEDCX (1000) have matching initial minimum investment requirements. MEDCX (5.87) and MEDBX (5.79) have marching annual gain over last year. MEDCX (10.80) and MEDBX (10.73) have equivalent 5 years return.
MEDBXMEDCXMEDBX / MEDCX
Total Expense Ratio1.811.81100%
Annual Report Gross Expense Ratio1.821.82100%
Fund Existence23 years23 years-
Gain YTD1.2541.33894%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets7.01B7.01B100%
Annual Yield % from dividends5.775.77100%
Returns for 1 year5.795.8798%
Returns for 3 years16.2816.3799%
Returns for 5 years10.7310.8099%
Returns for 10 years21.4121.47100%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMIX52.82N/A
N/A
Rydex Telecommunications Inv
FASIX13.69N/A
N/A
Fidelity Asset Manager 20%
IGEAX77.57N/A
N/A
VY® T. Rowe Price Growth Equity A
AVALX43.38N/A
N/A
Aegis Value I
MECEX14.13-0.03
-0.21%
NYLI Epoch Capital Growth Class C